Cleared Traditional

K120727 - MFM-CMS CENTRAL MONITORING SYSTEM

K120727 is the FDA 510(k) clearance for MFM-CMS CENTRAL MONITORING SYSTEM by Edan Instruments, Inc.. It is a Class 2 Cardiovascular device (product code MHX) cleared through the Traditional 510(k) pathway after a 469-day FDA review.

K120727 · Edan Instruments, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2013
Decision
469d
Days
Class 2
Risk

K120727 is an FDA 510(k) clearance for the MFM-CMS CENTRAL MONITORING SYSTEM. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Edan Instruments, Inc. (Shenzhen, CN). The FDA issued a Cleared decision on June 21, 2013 after a review of 469 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Edan Instruments, Inc. devices

Submission Details

510(k) Number K120727 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 09, 2012
Decision Date June 21, 2013
Days to Decision 469 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
344d slower than avg
Panel avg: 125d · This submission: 469d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 207
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K120727.
IM60/IM70 PATIENT MONITOR
K131971 · Edan Instruments, Inc. · Mar 2014
PHILIPS SURESIGNS CENTRAL
K131032 · Philips Medical Systems · Aug 2013
IMEC, IPM AND BENEVIEW T1 PATIENT MONITORS
K123074 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jul 2013
SURESIGNS VM4, SURESIGNS VM6, SURESIGNS VM8
K123900 · Philips Medical Systems · Apr 2013
PATIENT MONITOR
K120173 · Edan Instruments, Inc. · May 2012
PATIENT MONITOR
K113653 · Edan Instruments, Inc. · Feb 2012